Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FALCON: Fluciclovine (18F) PET/CT in Recurrent Prostate Cancer
NCT02578940Phase 3Completed
- Sponsor
- Blue Earth Diagnostics
- Start
- Nov 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluciclovine f 18 in prostate cancer (PCa), sponsored by Blue Earth Diagnostics. Started Nov 2015; status: completed.
02
Drugs
fluciclovine f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02578940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02578940.